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was irradiated receiving 50,4 Gy. The comorbidities 
associated were: 21% diabetes, 62,5% High blood pressure, 
40% cardiac pathology and 33 % were with anticoagulant 
treatment. All our haematuria patients have been handled 
following the next algorithm: Blood Test (Including platelets 
and liver parameters) and Urine Culture. If both are negative: 
Ultrasound (Kydney, urether and bladder). If haematuria goes 
on: Cystoscopy. 
 
Results: With a median follow-up of 52.5 months (range 5-
122 m), 48 patients (13%) have had haematuria. As etiological 
factors we have been found: Urine Infection 12 p (25%. Time 
32 months (12-70 m), Bladder cáncer 10 p (21%. Four of them 
a recurrence of a previous treated bladder tumour. Time: 32 
months (3-120 m), RADIATION CYSTITIS 10 p (21%. Time: 13 
months (6 – 38 m), Lithiasis 4 p (8%. Time: 25.5 months (26-
30 m), Local progression of Prostate cancer 1 p (2%). Time: 
72 months), Autolimited haematuria (Culture and image 
studies negatives. It does not repeat.): 9 p (19%. Time: 58 
months (25-80 m) and Fatal haematuria (Exitus. Not known 
etiology): 2 p (4%. Time: 78 and 84 months). 
 
Conclusion: In our experience, haematuria is a frecuent 
pathology in patients treated with radiotherapy of prostate 
cancer. The etiology of it spreading in similar proportions, 
across the different causes founded. The time of it 
presentation is important for the diagnostic. In the mind of 
the specialist must be different causes of it, NOT ONLY 
radiotherapy Cystitis taking in account that if it is due to 
radiotherapy it appears mainly, in the first two years after 
radiotherapy treatment. 
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Purpose or Objective: Volumetric modulated arc therapy 
(VMAT), a complex treatment strategy for intensity-
modulated radiation therapy, has been established clinically. 
While 5 mm thick MLC (L50) is a usual for VMAT, we have 
been using 2.5 mm thick MLC (L25) from 2012 to treat the 
prostate cancer. So we compared dosimetric, volumetric and 
dose delivering parameters between L25 and L50. 
 
Material and Methods: Twenty four cases were selected from 
our database. Those patients were treated for the prostate 
carcinoma in the feet-first prone position. Gantry angle range 
was 182 deg. to 178 deg. and collimation angle was set 0 deg. 
SmartArc system of Pinnacle3 was used with 6MVX physical 
data of Novalis Tx (L25) and 6MVX Siemens® ARTISTE 
physical data loaded on Varian Clinac-21 Ex (the base 
machine of Novalis) virtually (L50). The same consolidations 
for optimization were used. For example, Min Dose, D95 and 
Max Dose of PTV were 76 Gy, 80 Gy and 84 Gy, respectively. 
Rectal V40 was set to 20%. Wilcoxon rank sum test was 
applied to D98, D95, D50 and D02 of PTV, rectal V40, 
irradiation time and MU. To analyze relationships between 
these values and ROV grouped by L25 or L50, linear 
regression model was employed with analysis of covariance 
for the regression coefficients.  
 
Results: Mean values of D98, D95, D50 and D02, V40, Time 
and MU were 75.8 Gy, 77.5 Gy, 81.2 Gy, 84.2 Gy, 20.3%, 82.7 
sec and 646.6 for L25, and were 75.6 Gy, 77.3 Gy, 81.0 Gy, 
83.8 Gy, 19.6 %, 149.9 sec and 741.6 for L50, respectively. 
Only those mean values of D02, V40 and Time were 
significantly different between L25 and L50 by Wilcoxon test 
(Table). 
 
 
D98, D95, V40, Time and MU depended on ROV significantly. 
Slopes of valuables grouped by L25 and L50 were very similar 
in the all except Time and MU (Table and Figure). 
 
 
 
Conclusion: L25 and L50 plans were very similar from the 
dosimetric point of view (difference of D02 was significant 
but very small in value; 0.4Gy, L25>L50). From the 
volumetric (V40) point of view, difference was small (0.7%, 
L25>L50) but significant. In terms of dose delivery (Time), 
differences were remarkable and largely depend on the ROV 
especially in the cases of L50. We may use L50 with the 
expense of treatment time compared to L25. 
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Purpose or Objective: For patients with clinically localized 
prostate cancer with high probabilities to undergo adjuvant 
radiotherapy after radical prostatectomy(RP), radical 
radiotherapy may be a proper treatment option for saving 
time and medical costs. Our purpose is to develop 
nomograms combining PSA level, clinical T stage, and biopsy 
Gleason Score to predict probabilities of having indications 
for adjuvant radiotherapy including extraprostatic extension, 
positive margin, Gleason Score 8-10 and to provide data for 
individualizing initial treatment options. 
 
Material and Methods: We analyzed 214 men treated with RP 
between August 2013 and August 2015 at our hospital. 
Average age was 66 years. Men who enrolled in this study had 
a preoperative PSA level assessed before or at least 4 weeks 
after prostate biopsy, biopsy Gleason Score, pelvic MRI and 
clinical T stage (TNM 2009 classification). Men were excluded 
for preoperative treatment with neoadjuvant hormonal 
therapy, or transurethral resection of the prostate because of 
potential influence on pathologic stage or PSA level. 
Preoperative predictors included PSA level, clinical T stage 
(T2a/b, T2c, T3a, T3b), and biopsy Gleason score (5-6, 
3+4=7, 4+3=7, 8-10). These predictors were used in 
multivariable logistic regression analysis based nomograms to 
estimate the probabilities of extraprostatic extension, 
positive margin, Gleason Score 8-10 after RP, respectively. 
The predictive accuracy and discriminative ability of the 
